2023年度実績
- 2023.04.14 | 研究実績
2023年度業績
【英文論文】
Hamada S, Muramoto K, Akaike K, Okabayashi H, Masunaga A, Tomita Y, Ichiyasu H, Sakagami T. The impact of factor Xa inhibitors on bleeding risk in patients with respiratory diseases.
Scientific reports 2024;14:4039.
Tomita Y., Sakata S, Imamura K., Iyama S., Jodai T., Saruwatari K., Hamada S., Akaike K., Anai M., Fukusima K., Takaki A., Tsukamoto H., Goto Y., Motozono C., Sugata K., Satou Y., Ueno T., Ikeda T., Sakagami T.. Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations.
Cancers (Basel), 2023;16(1):47.
Fukuko Horio, Tokunori Ikeda, Yanosuke Kouzaki, Tomoo Hirahara, Kengo Masa, Sawana Narita, Yusuke Tomita, Shu Tsuruzoe, Akihiko Fujisawa, Yuki Akinaga, Yoko Ashizuka, Yuki Inoue, Ayaka Unten, Katsutoshi Okamura, Yuiko Takechi, Yasuhiro Takenouchi, Fuka Tanaka, Chiharu Masuda, Yusuke Sugimura, Yuji Uchida. Questionnaire survey on pharmacists’ roles among non- and health care professionals in medium-sized cities in Japan.
Scientific reports 2023 Apr 4;13(1):5458.
Hiroyuki Yamada, Rin Yamada, Yoshihiro Komohara, Remi Mito, Kazuchika Nishitsuji, Hiromu Yano, Yukio Fujiwara, Koei Ikeda, Makoto Suzuki. A Case of Aggressive Lung Squamous Cell Carcinoma With Aberrant Cytoplasmic p53 Aggregation.
Cancer Diagn Progn. 2024 Mar 3;4(2):204-208.
Miyu Imai, Hiroko Okabayashi, Kimitaka Akaike, Shohei Hamada, Aiko Masunaga, Hidenori Ichiyasu, Takuro Sakagami. Comparison of nintedanib-induced gastrointestinal adverse events between patients with systemic sclerosis-associated interstitial lung disease and idiopathic interstitial pneumonias.
Respiratory Investigation. 2024 May;62(3):317-321.
Hiroko Okabayashi, Seiya Nakashima, Kosuke Fujino, Miyu Imai, Shohei Hamada, Aiko Masunaga, Hidenori Ichiyasu, Makoto Suzuki, Takuro Sakagami. Tension Pneumomediastinum in Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease: A Case Report and Literature Review.
Internal Medicine. 2024 Apr 2.doi: 10.2169/internalmedicine.3418-23. Online ahead of print.
Yonesaka K, Hayashi H, Nakamura A, Sato Y, Azuma K, Sakata S, Tachihara M, Ikeda S, Yokoyama T, Ito K, Yano Y, Matsumoto H, Daga H, Hata A, Sakai K, Chiba Y, Nishio K, Yamamoto N, Nakagawa K.
Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single-Arm Phase II Trial.
Clin Lung Cancer 2023;24:519-527.
Imaji M, Fujimoto D, Sato Y, Sakata Y, Oya Y, Tamiya M, Suzuki H, Ikeda H, Kijima T, Matsumoto H, Kanazu M, Hino A, Inaba M, Tsukita Y, Arai D, Maruyama H, Hara S, Tsumura S, Kobe H, Sumikawa H, Sakata S, Yamamoto N. Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort study.
Eur J Cancer 2023;179:15-24.
Anai M, Saruwatari K, Imamura K, Fujino K, Jodai T, Sakata S, Iyama S, Tomita Y, Saeki S, Ichiyasu H, Ikeda K, Suzuki M, Sakagami T. Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an EGFR mutation.
J Thorac Dis. 2024 Feb 29;16(2):1151-1160.
Du C, Cai J, Tang J, Chen Y, Díaz-Peña R, Tomita Y, Jassem J, Zhao J, Zheng D, Tu Z. Cell-free DNA methylation profile potential in the diagnosis of lung squamous cell carcinoma.
J Thorac Dis. 2024 Jan 30;16(1):553-563.
Mito R, Iriki T, Fujiwara Y, Pan C, Ikeda T, Nohara T, Suzuki M, Sakagami T, Komohara Y. Onionin A inhibits small-cell lung cancer proliferation through suppressing STAT3 activation induced by macrophages-derived IL-6 and cell-cell interaction with tumor-associated macrophage.
Hum Cell. 2023 May;36(3):1068-1080.
Sakagami T. Evolution of asthma treatment goals.
Respir Investig. 2023 May;61(3):333-334.
Furukawa T, Akaike K, Iyama S, Masunaga A, Tomita Y, Saeki S, Ichiyasu H, Sakagami T. Interstitial Lung Disease in Adulthood Associated with Surfactant Protein C Gene Mutation in a Patient with a History of Lipoid Pneumonia in Infancy.
Intern Med. 2023 Sep 1;62(17):2521-2525.
Yamamoto S, Kuriyama H, Kashiwada-Nakamura K, Kajihara I, Makino K, Aoi J, Miyashita A, Yoshida C, Kubo Y, Fukushima S. A case of unknown primary melanoma detected with BRAF gene mutation from pleural fluid cell block.
J Dermatol. 2023;50:e305-e306.